Rhumbline Advisers Glaukos Corp Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Glaukos Corp stock. As of the latest transaction made, Rhumbline Advisers holds 141,790 shares of GKOS stock, worth $20.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
141,790
Previous 141,387
0.29%
Holding current value
$20.8 Million
Previous $18.4 Million
15.42%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding GKOS
# of Institutions
359Shares Held
49.7MCall Options Held
227KPut Options Held
444K-
Black Rock Inc. New York, NY8.04MShares$1.18 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$875 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$316 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$302 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$283 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.97B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...